Abstract
Pleural and pulmonary complications are common in the connective tissue disorders. Estimates of incidence depend on the methods used to detect them and, in patients with rheumatoid arthritis for example, have ranged from 2% when chest radiographs alone were used to 45% when pulmonary function tests were included. The main management decisions centre on the use of corticosteroids. These are very effective in suppressing some of the pleural and pulmonary complications but completely ineffective in others. The decision to use corticosteroids for specific respiratory problems must consider the effect of steroids on other aspects of these multisystem diseases. Steroid trials need care since, if steroid withdrawal is too abrupt, the underlying disease may flare up.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Useful References
Lungs in Systemic Disease
Basset F, Soler P, Jaurand MC, Bignon J (1977) Ultrastructural examination of broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X: preliminary report on 4 cases. Thorax 32: 303–306
Editorial (1985) Alveolar haemorrhage. Lancet II: 853–854
Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85
Lacronique J, Roth C, Battesti J-P, Basset F, Chretien J (1982) Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 37: 104–109
Macfarlane JD, Dieppe PA, Rigden BG, Clark TJH (1978) Pulmonary and pleural lesions in rheumatoid disease. Br J Dis Chest 72: 288–300
Morgan PGM, Turner-Warwick M (1981) Pulmonary haemosiderosis and pulmonary haemorrhage. Br J Dis Chest 75: 225–242
Alveolar Proteinosis
Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B (1975) Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 30: 121–132
Du Bois RM, McAllister WAC, Branthwaite MA (1983) Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax 38: 360–363
Pulmonary Eosinophilia
Geddes DM (1986) Pulmonary eosinophilia. J R Coll Phys Lond 20: 139–145
Lung Problems due to Drugs
Cooper JAD, White DA, Matthay RA (1986) Drug-induced pulmonary disease, Part 1: Cytotoxic drugs. Am Rev Resp Dis 133: 321–340
Cooper JAD, White DA, Matthay RA (1986) Drug-induced pulmonary disease, Part 2: Noncytotoxic drugs. Am Rev Resp Dis 133: 488–505
Darmanata JI, van Zandwijk N, Duren DR, van Royen EA, Mooi WJ, Plomp TA, Jansen HM, Durrer D (1984) Amiodarone pneumonitis; three further cases with a review of published reports. Thorax 39: 57–64
Gibson GJ (1983) Drug induced pulmonary disease. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds) Oxford textbook of medicine. Oxford University Press, Oxford, pp 101–103
Higenbottam T, Crome P, Parkinson C, Nunn J (1979) Further clinical observations on the pulmonary effects of paraquat ingestion. Thorax 34: 161–165
Holmberg L, Boman G (1981) Pulmonary reactions for nitrofurantoin. Eur J Resp Dis 62: 180–189
Lok-Wan Liu F, Cohen RD, Downar E, Butany JW, Edelson JD, Rebuck AS (1986) Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax 41: 100–105
Penn RG, Griffin JP (1982) Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland. Br Med J 284: 1440–1442
Proudfoot AT, Stewart MS, Levitt T, Widdop B (1979) Paraquat poisoning: significance of plasmaparaquat concentrations. Lancet II: 330–332
Van Barneveld PWC, Van der Mark ThW, Sleijfer DTh, Mulder NH, Schraffordt Koops H, Sluiter HJ, Peset R (1984) Predictive factors for bleomycin-induced pneumonitis. Am Rev Resp Dis 130: 1078–1081
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tattersfield, A.E., McNicol, M.W. (1987). The Lungs in Systemic Disease, Pulmonary Eosinophilia and Drug Reactions. In: Respiratory Disease. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3132-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3132-8_12
Publisher Name: Springer, London
Print ISBN: 978-3-540-16209-4
Online ISBN: 978-1-4471-3132-8
eBook Packages: Springer Book Archive